

Everything you need to know about Benzonatate in 2026 — what it is, how it's used, dosage guidelines, who should avoid it, and how much it costs.
If your doctor has prescribed Benzonatate — or you're wondering whether it might help your persistent cough — this guide covers everything you need to know. We'll walk through what it is, how it's used, proper dosing, important safety information, and what it costs in 2026.
Benzonatate is a non-narcotic prescription cough suppressant (antitussive). It was originally sold under the brand names Tessalon and Tessalon Perles by Pfizer, though the brand-name version has been largely discontinued. Today, Benzonatate is available exclusively as an affordable generic, manufactured by companies including Amneal, Ascend Laboratories, Sun Pharma, and Teva.
Unlike opioid-based cough suppressants like Codeine, Benzonatate is not a controlled substance. It doesn't carry the risk of dependence or abuse associated with narcotic cough medicines. It belongs to the antitussive drug class and is chemically related to local anesthetics like Tetracaine.
Benzonatate was approved by the FDA for the symptomatic relief of cough. It comes in three strengths:
Benzonatate is FDA-approved for one purpose: symptomatic relief of cough. It doesn't treat the underlying cause of your cough — it suppresses the cough reflex so you can rest and recover more comfortably.
Doctors commonly prescribe it for:
Benzonatate works best for dry, non-productive coughs. If your cough is producing a lot of mucus, your doctor may recommend a different approach — like an expectorant such as Guaifenesin (Mucinex) — or use Benzonatate alongside other treatments.
For a plain-English explanation of how the medication works in your body, see our article on how Benzonatate works.
Benzonatate is taken orally, usually 100 mg to 200 mg three times daily as needed. The maximum daily dose is 600 mg (three 200 mg capsules).
Critical instructions for taking Benzonatate:
If you miss a dose, take it as soon as you remember — unless it's close to time for your next dose. Never double up.
Benzonatate is not safe for everyone. Do not take it if you have:
Benzonatate is not approved for children under 10 years old. Accidental ingestion in young children has resulted in fatalities. The capsules resemble candy, making safe storage critical.
For pregnant or breastfeeding women, safety has not been established. Consult your doctor before use.
Older adults should use caution due to increased sensitivity to drowsiness and dizziness. For a complete overview of side effects, see our guide on Benzonatate side effects.
One of Benzonatate's biggest advantages is its affordability. As a widely available generic, it's one of the least expensive prescription cough medications on the market.
Here's what you can expect to pay in 2026:
Because it's a generic with multiple manufacturers, prices are competitive. The 200 mg capsules typically cost $9.50–$12 for 30 capsules.
For a complete guide to saving money — including discount card comparisons and patient assistance options — read How to Save Money on Benzonatate.
Benzonatate is a safe, effective, and affordable option for managing persistent cough. It's not a narcotic, it doesn't cause dependence, and it works quickly. The most important thing to remember is to always swallow the capsule whole and keep it away from young children.
If your cough is disrupting your life, talk to your doctor about whether Benzonatate is right for you. And when you're ready to fill your prescription, Medfinder can help you find it in stock at a pharmacy near you.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.